Skip to content

Effect of Dezocine on Pain and Immune Function for Patient-controled Intravenous Analgesia after Thoracic Surgery

Effect of Dezocine on Pain and Immune Function for Patient-controled Intravenous Analgesia after Thoracic Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOC-14005468
Enrollment
Unknown
Registered
2014-11-11
Start date
2014-11-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracic surgical patients

Interventions

dezocine and sulfentanyl group:dezocine and sulfentanyl
sulfentanyl group:sulfentanyl

Sponsors

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: ASA physical status I or II patients, aged 18-60 years old, undergoing general anesthesia for elective thoracic surgery.

Exclusion criteria

Exclusion criteria: Patients with adrenal cortex dysfunction, neuro-logic disease, psychiatric disorders, drug allergy, or who had received sedatives, analgesics, or opioids within the previous 24 h were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;Ramsay scores;the number of pressing the analgesia pump;

Secondary

MeasureTime frame
systolic pressure;diastolic pressure;heart rate;Pulse Oxygen Saturation;Analgesia satisfaction score;

Contacts

Public ContactTieli Dong
tlddtl@126.com+86 0371-63620723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026